Moore Amelia E B, Hain Sharon F, Blake Glen M, Fogelman Ignac
Department of Nuclear Medicine, Guy's Hospital, London, United Kingdom.
J Nucl Med. 2003 Jun;44(6):891-7.
Quantitative studies of the kinetics of (99m)Tc-methylene diphosphonate ((99m)Tc-MDP) in metastatic and metabolic bone disease require the measurement of free tracer in plasma to derive the input function. Several methods of measuring free (99m)Tc-MDP have been described including ultrafiltration, precipitation using trichloroacetic acid, and a direct in vivo measurement based on the assumption that free MDP is cleared through the kidneys by glomerular filtration. The aim of this study was to validate ultrafiltration as a convenient and accurate method of measuring the free fraction of (99m)Tc-MDP by comparing it with the glomerular filtration rate (GFR) method. A second aim was to measure the percentage of free (99m)Tc-MDP in a cross-section of patients using ultrafiltration to determine the interpatient variability and, therefore, whether individual measurements are required for bone kinetic studies.
In study 1, 10 volunteers (7 women, 3 men; mean age, 37 y; range, 26-55 y) were injected with 3 MBq (99m)Tc-MDP and 3 MBq (51)Cr-ethylenediaminetetraacetic acid, and multiple blood and urine samples were taken between 0 and 4 h. Plasma samples were spun in 5-, 10-, and 30-kDa filters and counted in a gamma-counter. In study 2, 51 randomly selected patients (26 women, 25 men; mean age, 66 y; range, 31-87 y) attending our department for a routine bone scan were injected with 600 MBq (99m)Tc-MDP, and 4 blood samples were taken between 0 and 4 h and spun in 10-kDa filters.
In study 1, the mean percentages (+/-SD) of free (99m)Tc-MDP at 5 min and 4 h after injection measured using the 10-kDa filters were 83.1% +/- 3.4% and 44.0% +/- 10.0%. The mean ratios (+/-SEM) of the free (99m)Tc-MDP in ultrafiltrate compared with the GFR method for the 5-, 10-, and 30-kDa filters were 0.894 +/- 0.010, 0.943 +/- 0.009, and 0.987 +/- 0.010. In study 2, the mean percentages (+/-SD) of free (99m)Tc-MDP at 15 min and 4 h were 75.3% +/- 8.0% and 48.8% +/- 9.5%, with a precision error of 2.3%. The percentages of free MDP at 150 min and 4 h were significantly correlated with GFR but not with serum albumin.
Ultrafiltration provides an accurate method of evaluating free (99m)Tc-MDP in plasma for bone kinetic studies. The results from both the healthy volunteers in study 1 and the patients in study 2 show that protein binding varied with time and showed significant differences between individuals that were partly dependent on GFR. It is thus necessary to measure individual protein binding values for bone kinetic studies.
对转移性和代谢性骨病中(99m)锝 - 亚甲基二膦酸盐((99m)Tc - MDP)动力学进行定量研究时,需要测量血浆中的游离示踪剂以获得输入函数。已描述了几种测量游离(99m)Tc - MDP的方法,包括超滤、使用三氯乙酸沉淀以及基于游离MDP通过肾小球滤过经肾脏清除这一假设的直接体内测量。本研究的目的是通过将超滤与肾小球滤过率(GFR)方法进行比较,验证超滤作为一种方便且准确的测量(99m)Tc - MDP游离分数的方法。第二个目的是使用超滤测量一组患者中游离(99m)Tc - MDP的百分比,以确定患者间的变异性,从而确定骨动力学研究是否需要进行个体测量。
在研究1中,10名志愿者(7名女性,3名男性;平均年龄37岁;范围26 - 55岁)被注射3 MBq(99m)Tc - MDP和3 MBq(51)铬 - 乙二胺四乙酸,并在0至4小时内采集多个血液和尿液样本。血浆样本在5 kDa、10 kDa和30 kDa的滤器中离心,并在γ计数器中计数。在研究2中,51名随机选择的到我们科室进行常规骨扫描的患者(26名女性,25名男性;平均年龄66岁;范围31 - 87岁)被注射600 MBq(99m)Tc - MDP,并在0至4小时内采集4份血液样本,并在10 kDa的滤器中离心。
在研究1中,使用10 kDa滤器在注射后5分钟和4小时测量的游离(99m)Tc - MDP的平均百分比(±标准差)分别为83.1% ± 3.4%和44.0% ± 10.0%。与GFR方法相比,5 kDa、10 kDa和30 kDa滤器中超滤液中游离(99m)Tc - MDP的平均比值(±标准误)分别为0.894 ± 0.010、0.943 ± 0.009和0.987 ± 0.010。在研究2中,15分钟和4小时时游离(99m)Tc - MDP的平均百分比(±标准差)分别为75.3% ± 8.0%和48.8% ± 9.5%,精确误差为2.3%。150分钟和4小时时游离MDP的百分比与GFR显著相关,但与血清白蛋白无关。
超滤为骨动力学研究评估血浆中游离(99m)Tc - MDP提供了一种准确的方法。研究1中的健康志愿者和研究2中的患者的结果均表明,蛋白质结合随时间变化,且个体之间存在显著差异,部分取决于GFR。因此,骨动力学研究有必要测量个体的蛋白质结合值。